Learn more

CLONATEC SA

Overview
  • Total Patents
    21
About

CLONATEC SA has a total of 21 patent applications. Its first patent ever was published in 1986. It filed its patents most often in France, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are SANQUIN BLOEDVOORZIENING, CANAG DIAGNOSTICS AB and CANVEST WUHAN BIOTECHNOLOGY CO LTD.

Patent filings per year

Chart showing CLONATEC SAs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Somme Gerard 8
#2 Gerard Somme 8
#3 Vincent Christian 4
#4 Joannes Martine 4
#5 Serre Guy 4
#6 Denis Adda 3
#7 Pouletty Philippe 3
#8 Jacques Martin 3
#9 Lebacq Philippe 3
#10 Martin Jacques 2

Latest patents

Publication Filing date Title
FR2701567A1 Test device for analysing biological samples
WO9219649A1 Antigens recognized by antibodies of rhumatoid polyarthritis, and preparation and use thereof
FR2683911A1 DIAGNOSTIC REAGENT, ITS APPLICATIONS IN A METHOD FOR RAPID QUALITATIVE AND QUANTITATIVE DETERMINATION OF AN ANALYTE IN A FLUID TO BE TESTED AND DEVICE FOR IMPLEMENTING SAID METHOD.
FR2681600A1 Antigens specifically recognized by specific antibodies for rhumatoid polyarthritis, their constitutive proteins, their preparation and their applications.
FR2679254A1 OLIGONUCLEOTIDE PROBES FOR THE TYPING AND DETECTION OF HUMAN PAPILLOMAVIRUSES.
FR2675805A1 Antigens specific for rheumatoid arthritis, their constituent proteins, their preparation and their diagnostic application
FR2671554A1 HEPATITIS B VIRUS-BASED HBC ANTIGEN SYNTHETIC PEPTIDES, THEIR USE IN THE DETECTION OF VIRUS INFECTION AND VACCINATION AGAINST HEPATITIS B.
FR2657167A1 Method for in vitro prenatal screening for fetal trisomy in a biological sample likely containing hcg and necessary for its implementation.
FR2657017A1 Peptides derived from the glycoprotein envelope of the hiv-1 virus, their applications for the detection of an infection due to this virus and for vaccination against aids.
FR2657016A1 Peptides derived from the glycoprotein envelope of the hiv-2 virus, their applications for the detection of an infection due to this virus and for vaccination against aids.
FR2652900A1 Process for immunological analysis of the "sandwich" type, its application to the prenatal detection in vitro of trisomy 21 and kit for its implementation
FR2598435A1 METHOD AND DEVICE FOR THE DETECTION OF DNA AND RNA VIRAL GENOMES IN BIOLOGICAL MEDIA, IN PARTICULAR IN THE BLOOD SERUM